Quick Answer
Medinotec Inc. reported Operating Income Loss of $3.19 million for the year ending 2025.
- Medinotec Inc. showed an increase of +431.4% in Operating Income Loss from 2024 to 2025.
- This data is from Medinotec Inc.'s annual report (Form 10-K), filed with the SEC on May 29, 2025.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: -$70.2 thousand | Q2 2022: -$48.0 thousand | Q3 2022: -$172.6 thousand | Q3 2022: $25.5 thousand | Q4 2022: $25.5 thousand | Q2 2023: $40.9 thousand | Q3 2023: $55.7 thousand | Q4 2023: $257.9 thousand | Q2 2024: $269.2 thousand | Q3 2024: $435.7 thousand | Q4 2024: $527.5 thousand | Q2 2025: $277.5 thousand | Q3 2025: $528.6 thousand | Q4 2025: $552.7 thousand.
- Over the full 3 years of available data (2023 to 2025), Medinotec Inc.'s Operating Income Loss has grown by 1,437.7%.
- Historical annual values: Fiscal year 2025: $3.19 million | Fiscal year 2024: $600.6 thousand | Fiscal year 2023: -$238.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: